A pilot, parallel-group, blinded, placebo-controlled, randomiseD, pRagmatic clinical trial investigating the Effect of temazepAM on objective and subjective measures of sleep in critically ill patients (the DREAM trial)
Retrospectively registered with the Australian and New Zealand Clinical Trials Registry on 11th June 2021 (ACTRN 12621000742875).
Authors
- Laurie Showler (ORCID: https://orcid.org/0000-0002-0080-7811)
- Brianna Tascone
- Jeffrey Presneill (ORCID: https://orcid.org/0000-0001-7177-7667)
- Jeremy Goldin (ORCID: https://orcid.org/0000-0001-7230-8248)
- Andrew C. Perkins (ORCID: https://orcid.org/0000-0003-3644-7093)
- Barry V. Johnston
- Mark Philip Plummer (ORCID: https://orcid.org/0000-0002-9640-1911)
- Melissa J. Ankravs (ORCID: https://orcid.org/0000-0002-0990-997X)
- Kirk Kee
- Yasmine Ali Abdelhamid
- Kathleen Byrne
- Adam M. Deane
- Cara Moore
Institutions
- Royal Adelaide Hospital (AU)
- The Royal Melbourne Hospital (AU)
- Monash University (AU)
- The University of Adelaide (AU)
Publication Details
- Journal
- Critical Care and Resuscitation
- Published
- 2026-02-19
- DOI
- https://doi.org/10.1016/j.ccrj.2026.100169
- Primary Topic
- Intensive Care Unit Cognitive Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Australian Government